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Abstract 
To select he gene coding for an isoleucine permease, an isoleucine dependent strain (ih,1 chal) was transformed with a yeast genomic 
multicopy library, and colordes growing at a low isoleucine concentration were selected. Partial sequencing of the responsible plasmid 
insert revealed the presence of a previously sequenced 609 codon open reading frame of chromosome II with homology to known 
permeases. Deletion, extra dosage and C-terminal truncation of this gene were constructed in a strain lacking the general amino acid 
permease, and amino acid uptake was measured uring growth in synthetic omplete medium. The following observations prompted us to 
name the gene BAP2 (branched-chain amino acid permease). Deletion of BAP2 reduced uptake of leucine, isoleucine and valine by 
25-50%, while the uptake e,f 8 other L-a-amino acids was unaltered or slightly increased. Introduction of BAP2 on a centromere-based 
vector, leading to a gene dosage of two or slightly more, caused a 50% increase in leucine uptake and a smaller increase for isoleucine 
and valine. However, when the 29 C-terminal codons of the plasmid-borne copy of BAP2 were substituted, the cells more than doubled 
the uptake of leucine, isoleucine and valine, while no or little increase in uptake was observed for the other 8 amino acids. 
Keywords: Yeast; Amino acid transport; Leucine; lsoleucine; Valine 
1. Introduction 
The yeast Saccharomyces cerevisiae takes up amino 
acids from the medium through amino acid permeases, 
driven by proton symport [1]. So far, 12 known or putative 
L-a-amino acid permease genes from S. cerevisiae, shar- 
ing homology, have been cloned and sequenced, and trans- 
port specificities have been indicated for 7 of them, the 
general amino acid permease, Gap lp, [2], and the perme- 
ases for arginine (Canlp) [3], lysine (Lyplp) [4], proline 
(Put4p) [5], histidine (Hiplp) [6], tyrosine (Tatlp) and 
tryptophan (Tat2p) [7]. All the genes contain features 
corresponding to a suggested 12-transmembrane alpha he- 
lix structure. 
The activity of at least some amino acid permeases i
regulated by the availability of nitrogen sources in the 
medium. Some of them are active only if the nitrogen is 
present in a form which is relatively difficult to utilize, 
e.g., proline or urea. These permeases include Gaplp (the 
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general amino acid permease), a low specificity, high 
capacity permease that transports L-a-amino acids, includ- 
ing some that do not occur in proteins, such as citrulline 
and omithine [8], many o-amino acids, several toxic amino 
acid analogs and other amino acid-related compounds. 
Other members of this group are Uga4p, which transports 
GABA (4-aminobutyric acid), and the proline permease, 
Put4p. 
The regulation of Gaplp activity has been studied to 
some extent. Upon addition of ammonia, the permease 
synthesis is repressed at the transcriptional level, and the 
permease is inactivated at the protein level. The inactiva- 
tion seems to involve dephosphorylation f the molecule 
near the C-terminal [9,10]. Thus an intact C-terminus is 
probably important for the regulation of activity, but not 
for the transport activity as such. The NPRI gene product 
is necessary for reactivation of Gaplp and other 
ammonia-sensitive p rmeases on de-repressing medium 
[11,12]. The NPRI gene has been cloned and encodes a 
putative protein kinase [13]. 
In media rich in ammonia or glutamate, Gaplp has poor 
activity, while other, more specific permeases are active, 
such as lysine permease [14], arginine permease [15], and 
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histidine permease [16]. Regulation of the amino acid 
permeases that are active in the presence of easily assimil- 
able nitrogen sources has been studied to a lesser extent 
than regulation of Gap lp, and the mechanisms of regula- 
tion are unknown. Two main patterns have so far ap- 
peared. The presence of an amino acid, such as serine, in 
the medium may induce the uptake of the same amino acid 
[17,18]. On the other hand, preloading of yeast cells with 
an amino acid may decrease further uptake of the same 
amino acid [ 16,19]. 
We are interested in uptake of the branched-chain amino 
acids leucine, isoleucine and valine, which can take place 
under conditions that inhibit and repress Gaplp. Uptake 
kinetics can be interpreted as consisting of two Michaelis- 
Menten-obeying systems in addition to Gap lp [20,21], but 
the number of involved permeases and their (its) regulation 
are not known. An approach to these questions is isolation 
of the structural gene(s) for the permease(s). Tullin et al. 
[20] isolated a mutant, bapl, exhibiting decreased uptake 
and somewhat simplified kinetics of uptake of leucine, 
isoleucine and valine. However, further work (M.U. 
JOrgensen, C. Gjermansen and M.C. Kielland-Brandt, un- 
published) has shown that the bapl mutation is not in the 
structural gene for a permease and that it affects the uptake 
of a broad range of amino acids. In the present work a 
different approach was taken to isolate a structural gene 
for a permease for one or more of the three amino acids. It 
was envisaged that the growth deficiency of an isoleucine 
requiring strain on a medium low in isoleucine might be 
compensated by overexpression of the gene encoding a 
permease for this amino acid. Selection of cells trans- 
formed with a genomic library yielded a gene which 
indeed has homology to known amino acid permeases. 
Deletion and extra dosage, respectively, of the gene gave 
phenotypes indicating that the encoded permease is rather 
specific for the branched-chain amino acids. Deletion of 
the codons for the 29 most C-terminal amino acid residues 
stimulated uptake, suggesting that these residues have a 
regulatory role. 
2. Materials and methods 
2.1. Strains and media 
Minimal ammonia (MA) medium contains per litre: 10 
g succinic acid, 6 g NaOH, 5 g (NH4)2SO 4, 1.7 g Bacto 
yeast nitrogen base without amino acids and without am- 
monium sulfate (Difco), and 22 g D-glucose monohydrate. 
Minimal proline (MP) medium is MA with 2 g/ I  proline 
instead of (NH4) 2 SO 4. Synthetic omplete (SC) medium is 
MA supplemented with the following nutrients per litre: 20 
mg adenine, 20 mg L-arginine, 300 mg L-aspartic acid, 100 
mg L-glutamic acid, 20 mg L-histidine, 30 mg L-isoleucine, 
30 mg L-ieucine, 30 mg L-lysine, 60 mg L-methionine, 50 
mg L-phenylalanine, 375 mg L-serine, 600 mg L-threonine, 
20 mg L-tryptophan, 30 mg L-tyrosine, 20 mg uracil and 30 
mg L-valine. FOA medium contains per litre: 7 g yeast 
nitrogen base without amino acids (Difco), 1 g 5-fluoro- 
orotic acid, 50 mg uracil, 20 g D-glucose and 2% agar [22]. 
S. cerevisiae strains used in this study are: M2409 
(MATte ura3-52 ih'l-lO chal-1 trpl) [23], M3750 (MATa 
gal2 ura3) [24], M4054 (MATa gal2 ura3 gapl) (this 
study) and M4056 (MATa gal2 ura3 gapl bap2) (this 
study). With the exception of M2409, the strains are 
isogenic to $288C [25]. 
2.2. Amino acid uptake 
An overnight culture was diluted and grown to a cell 
density corresponding to OD6o 0 0.5-0.7 (0.065-0.90 mg 
dry weight/ml) on the indicated medium at 30°C. Cells 
were harvested from 20 ml of culture and resuspended in 
700 /zl SC medium, and 100 /xl of this suspension were 
added to 150 /xl SC containing 0.1 /zCi radiolabeled 
amino acid. After 5 min, uptake was stopped by addition 
of 0.5 ml ice-cold 150-250 mM of the corresponding 
non-radioactive amino acid. The cells were collected on a 
glass fiber filter (GC50, Advante Toyo), washed three 
times with cold SC medium, dried and counted in a 
Beckman L8S 6000IC scintillation counter. For alanine 
uptake, all SC media were supplemented with 30 mg/l  
L-alanine. Radiolabeled amino acids were obtained from 
New England Nuclear and were; L-[HC(U)]leucine 
(NEC279E), L-[14C(U)]isoleucine (NEC278E), L- 
[14C(U)]valine (NEC291E), L-[14C(U)]glutamic acid 
(NEC290E), L-[side chain-3-14C]tryptophan (NEC367E), 
L-[Jac(u)]tyrosine (NEC289E), L-[14C(U)]phenylalanine 
(NEC284E), L-[14C(U)]histidine (NEC277E), L-[methyl- 
14C]methionine (NEC165E) and e-[14C(U)]alanine 
(NEC266E). All uptake measurements were made in dupli- 
cate, and average values are given. 
2.3. Construction ofthe Agapl and Abap2 alleles 
Plasmid pJCJ252 (kindly supplied by M. Grenson) [2] 
was digested with SphI, and the fragment containing the 
GAPI gene was inserted into the SphI site of pBR322 [26], 
generating plasmid pTD4. Plasmid pTD4 was digested 
with KpnI and NspV, removing a 1396 bp fragment of the 
open reading frame of the GAPI gene. The plasmid was 
resealed by blunting the ends with T4 DNA polymerase 
and ligation, resulting in plasmid pTD5. The 2.5 kb SphI 
fragment containing the Jgapl allele was excised from 
pTD5 and subcloned into the unique SphI site in plasmid 
pTDI, a YIp5 [27] derivative where the EcoRI and HindlII 
sites have been removed by cutting with both enzymes, 
Klenow filling and ligation. One of the resulting plasmids 
(pTD6) was linearized with EcoRI and used to transform 
the ura3 strain M3750. Selection for uracil independence 
resulted in integration of the Agapl allele into the chromo- 
somal locus of GAP1, and subsequent selection on FOA 
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1827 bp 
HindlII ClaI ClaI BamHI SaeI HindIII 
A 
Leu3p Gcn4p 
Fig. 1. The BAP2 gene. Based upon the published sequence [32], 
positions of relevant restrictiov sites, coding region (1827), putative 
TATA boxes and putative binding sites for transcription activators are 
indicated. Shaded area indicates the 786 bp stretch deleted in the Abap2 
construct. 
about 750 bp upstream and 450 bp downstream of the 
deletion for integration. It was opened at the BamHI site 
before transformation of the Agapl strain M4054. The 
Ura ÷ colonies were plated on FOA medium and some of 
the 5-FOA-resistant colonies were replica-plated to SC + 
100 mg/1 metsulfuron methyl (MM), which inhibits the 
actohydroxyacid synthase (IIv2p), thereby blocking biosyn- 
thesis of isoleucine and valine. Colonies with a growth 
defect on this medium were selected, and verified by 
Southern hybridization to carry the bap2 deletion (data not 
shown). 
plates yielded colonies having lost the vector and either 
allele [28,29]. A clone containing only the Agapl allele 
was identified by Southern analysis and [Inc]citrulline 
uptake measurement (da~m not shown) and designated 
M4054. Also BAP2 was deleted by the loop in/loop out 
strategy. A 786 bp ClaI fragment situated 60 bp from the 
start codon was removed (cf. Fig. 1), and the HindlII-SacI 
fragment was inserted into the integration vector pRS306 
[30] to form the plasmid pMGI2. This construct offers 
3. Results 
3.1. Isolation of the BAP2 gene 
To isolate the gene for a permease for one (or more) of 
the three branched-chain amino acids, leucine, isoleucine 
and valine, we assumed that cells under limitation for 
isoleucine could overcome growth retardation when pro- 
vided with extra copies of the permease gene. To accom- 
1 
Bap2p MlssedFgss gkketspdsI sIrS.Fsagn nfqssSsekt ySkqksGSdk IihrFaDSFK 
Gaplp MsntssYekn npdnlkhngI tIdSeFltqe pitipSngsa vSidetGSgs kwqdFkDSFK 
61 
Bap2p Raegsttrtk qlneNtSDiE dgVesITsds kLKksMKsRH vvMmslGtgI GTGLLVanak 
Gaplp R ..... vkp£ eVdpNISEaE k.VaiITaqt pLKhhLKnRH lqMiaiGgaI GTGLLVgsgt 
121 
Bap2p gLhyGGPAaL iIGYilvsfe tYfMIqAaGE MAVtYPtlpa nFnaYssiFI skSFGFAtvW 
Gaplp aLrtGGPAsL iIGWgstgtm iYaMVmAIGE LAViFP.isg gFttYatrFI deSFGYAnnF 
181 
Bap2p IYcFQWLtVL PLEIItASmT IqF.GnDkin pDiYIliFYv flVfIhfFGV KaYGEtEFIF 
Gaplp nYmLQWLvVL PLEIVsASIT VnFwGtDpky EDgFValFWI aiViInmFGV KgYGEaEFVF 
241 
Bap2p nccKIlmIaG FIILsIViNC GGagndGYIG atYWHnPGAF AGDTsigrFK nVCyILVTAy 
Gaplp sfiKVitVvG FIILgIIINC GGgptgGYIG gkYWHdPGAF AGDTpgakFK gVCsVFVTAa 
301 
Bap2p FSFgGmELfa LsvqEqsnPR KStPvAAKrs iYRIvviYiL tMiLIGFnVP YNDdqLmGAg 
Gaplp FSFaGsELvg LaasEsvePR KSvPkAAKqv fWRItlfYiL sLIMIGLIVP YNDksLiGAs 
361 
Bap2p gsathASPYV IAasiHGVKi vPhIINaVIL IsVvSVaNSs iYAgpRlics LAqQgYaPkf 
Gaplp svdaaASPFV iAiktHGIKg IPsVVNvVIL IaVISVgNSa iYAcsRtmva LAeQrFIPei 
421 
Bap2p LdYVDReGRP LraliVccvF GvIAFVAASs KEeiVFtWLa AiaGLSeLFT WtsImlsHiR 
Gaplp FsYVDRkGRP LvgiaVtsaF GIIAFVAASk KEgeVFnWLI AIsGLSsLFT WggIcicHiR 
481 
Bap2p FRqAMkvQGR sLDELgYKat TGIWGSiYGv FfnIlvFVAQ FWVAIaPIGn ggkcdAEsFF 
Gaplp FRkALaaQGR gLDELsFKsp TGVWGSyWG1 FmvIimFIAQ FYVAvfPvGd sp..sAEgFF 
541 
Bap2p qnYLaFPiwL afYfGymVYn RdFtLLnPID KiDIDfhRRi yDpELMrQEd eEnKekLrnm 
Gaplp eaYLsFPIvM vmYiGhkIYk RnWkLFiPaE KmDiDtgRRe vDIDLLkQEi aEeKaiMatk 
601 
Bap2p slmrkaYhFW C 
Gaplp prwyriWnFW C 
Fig. 2. Alignment of amino acids residues of the Bap2p permease and the general amino acid permease, Gaplp. Conserved amino acids are indicated with 
capital etters. The alignment was made by the Pileup program, with a gap weight of 3.0 and a gap length weight of 0.1. 
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modate the possibility of highly specific permeases, growth 
limitation was performed by starvation for only one of the 
three amino acids, and isoleucine was chosen in this work. 
ilvl mutants require isoleucine for growth, while they 
require neither valine nor leucine, being defective in the 
anabolic threonine deaminase which converts threonine to 
the first committed intermediate in isoleucine biosynthesis, 
2-oxobutyric acid. A yeast strain carrying a mutation in 
ilvl was chosen as the host strain for screening a multi-copy 
genomic library [31] with selection for growth on low (20 
/zM) concentration of isoleucine. However, ilvl mutants 
are subject to the occurrence of spontaneous suppressor 
mutations, which act by de-repressing CHA1, encoding a 
catabolic threonine deaminase, i.e., an isoenzyme of I lvlp 
[23]. The strain was therefore chosen to also carry a chal 
mutation, and the presence of the ura3-52 marker allowed 
concomitant selection for vector sequences. Among 50 000 
Ura + transformants, about 200 were able to grow on 20 
/xM isoleucine. These transformants were tested for con- 
comitant loss of this phenotype and the Ura ÷ phenotype, 
and it was ascertained that they were still unable to grow 
on plates without isoleucine. Eight clones passed these 
screens. Uptake of amino acids was measured during 
logarithmic growth, and 7 transformants were found to 
have increased uptake of all three branched-chain amino 
acids (data not shown). From three transformants the plas- 
mids were propagated through E. coli and tested for the 
retransformation phenotype. Two of the plasmids had in- 
serts with identical restriction maps, and one of these was 
chosen for further analysis. The third plasmid has not yet 
been analysed. 
3.2. Nucleotide sequence analysis of BAP2 
The cloned fragment was about 8 kb, and sequencing of 
about 300 bp from both ends of an approx. 3 kb HindlII 
fragment (cf. Fig. 1) revealed identity with a sequence 
including the stop codon of an ORF called YBR068c, 
located on the right ann of chromosome II [32], and with a 
derived amino acid sequence having strong homology to 
other known amino acid permeases. This ORF is situated 
only 888 bp downstream of the gene for another amino 
acid permease, TAT1 [7]. TAT1 is supposed to be a perme- 
ase for tyrosine, and the two genes are transcribed in the 
same direction. 
BAP2 has an open reading flame of 1827 bp and 
encodes a polypeptide with a calculated molecular mass of 
78 446 kDa. There are three potential glycosylation sites, 
Asn-Xxx-Ser or Asn-Xxx-Thr, at positions Asn74, Asn396 
and Asn597. The promoter has three closely situated puta- 
tive TATA-boxes, and contains the recognition sequence 
5'TGACTC, for the transcription activator Gcn4p mediat- 
ing general amino acid control [33]. The promoter also 
contains the Leu3p recognition sequence 5'CCGGNNC- 
CGG at position -385  bp. Leu3p is a transcription activa- 
tor of a group of genes involved in leucine biosynthesis 
300 
250 
~ 200 
1so o 
¢J 
100 
50 
Leu ne Val Glu His Tyr Phe Trp Met Ser Ala 
Fig. 3. Uptake of 14C-labeled amino acids as influenced by genetic changes of BAP2. Uptake was measured uring exponential growth on SC or SC 
without uracil, the latter for strains carrying URA3-containing plasmids. All strains were isogenic and deficient in the general amino acid permease. Open 
bars, strain M4056, deficient in Bap2p. Light shading, control strain M4054, wild-type for BAP2. Darker shading, same strain, except hat it carries the 
centromere-based plasmid pMG1 with BAP2. Closed bars, same strain, except hat the plasmid-borne BAP2 gene is truncated for the 29 most C-terminal 
codons. 
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[34]. The 3' non-coding end has the 5'TAG...TAG...(A/T 
rich)...TTT signal for transcription termination of mRNA 
in yeast [35]. The 5'AATAAA sequence for polyadenyla- 
tion in higher eukaryotes cannot be found. 
In a comparison of the deduced amino acid sequence of 
BAP2 with known permease sequences, the best homology 
is found to Gaplp [2] (68%). An even higher homology 
(84%) is seen to a putative amino acid permease, Paplp 
[36]. Fig. 2 shows the derived amino acid sequence of 
Bap2p aligned with the general amino acid permease, 
Gaplp. 
3.3. Phenotype of a bap2 deletion 
From a physiological point of view, the capacity, regu- 
lation, etc., of the more specific amino acid permeases are 
of primary interest on media that repress and/or inhibit 
the general amino acid permease, Gaplp, such as synthetic 
media which have ammonium as nitrogen source, e.g., MA 
and SC, simply because of the high capacity of Gaplp. SC 
(synthetic omplete medium) was chosen in most of this 
work. However, somewhat dependent on the strain, Gaplp 
is not necessarily negligible on ammonium-containing me- 
dia. To eliminate transport through Gaplp, a gapl deletion 
was constructed, and the resulting strain was used as the 
control strain in all uptake experiments and the parent for 
isogenic derivatives affected in BAP2, analysed in these 
experiments. 
A deletion in BAP2 was made by removing a 786 bp 
fragment, situated 60 bp into the gene from the start 
codon. Fig. 3 shows the amino acid uptake in the bap2 
strain in percentage of the control, i.e., the M4054 strain 
(Agapl BAP2). For this strain, uptake values in 
nmol/min × mg dry weight of cells were: leucine, 0.5; 
isoleucine, 0.2; valine, 0.1; glutamic acid, 0.1; histidine, 
0.4; alanine, 0.04; phenylalanine, 0.6; tyrosine, 0.4; trypto- 
phan, 0.1; methionine, 0.4; and serine, 1.8. Uptake in 
M4056 (Agapl Abap2) of leucine and valine decreases to 
about 55%, and the uptake of isoleucine to about 75% of 
the control with the intact BAP2 gene. Uptake of all other 
measured amino acids is unaltered or moderately in- 
creased, suggesting a high specificity of Bap2p. This is 
taken to mean that Bap2p is responsible for a large part of 
the uptake of the three branched-chain amino acids. Con- 
sidering the size of the bap2 deletion, it is likely that the 
remaining uptake goes via one or more other permeases. 
3.4. The effect of moderately increased gene dosage 
To measure the effect on amino acid uptake of an extra 
copy of the BAP2 gene, the BAP2 (Agapl)control strain, 
M4054, was transformed with plasmid pMGI, consisting 
of the centromere-based w~ctor pRS316 [30], with a 4.1 kb 
ScaI fragment inserted into the SmaI site. pMG1 contains 
an intact BAP2 gene, with about 2 kb upstream sequences 
and 0.3 kb sequences downstream of the coding region. 
The transformant shows about 50% increase in the uptake 
of leucine and a smaller increase in the uptake of isoleucine 
and valine (Fig. 3). Uptake of the other measured amino 
acids changed less. When the Abap2 strain (M4056) was 
transformed with the same construct, uptake of the 
branched-chain amino acids was restored to the level seen 
in the BAP2 control strain (M4054) (data not shown). 
3.5. Phenotype of a C-terminal truncation 
During a separate study (H.A. Andersen, unpublished) 
involving the closely linked TAT1 gene [7], a 6 kb Sau3A 
fragment in the centromere-based v ctor pRS316 was found 
to markedly increase branched-chain amino acids uptake. 
The insert turned out to contain BAP2 except for the last 
87 nucleotides of the coding region, resulting in the substi- 
tution of the 29 most C-terminal amino acids, with a 
sequence of vector-encoded amino acids. In order to study 
the effect of this truncation without adding an extra copy 
of TAT1, plasmid pMG20 was constructed, consisting of a 
3.1 kb SpeI-Sau3A fragment ligated into the SpeI and 
BamHI sites of pRS316. When introduced into the BAP2 
control strain (M4054), the plasmid caused a doubling in 
the uptake of leucine, more than a doubling in the uptake 
of isoleucine and nearly a three times higher uptake of 
valine (Fig. 3). Again, uptake of the other measured amino 
acids was only modestly affected. 
4. Discussion 
In the present paper we identify a gene, BAP2, encod- 
ing an amino acid permease involved in the transport of 
the three branched-chain amino acids in S.cerevisiae. Eight 
other common amino acids, including those (phenyl- 
alanine, methionine, alanine) which, in hydrophobicity, 
etc., resemble the branched-chain amino acids, showed no 
clear sign of being transported by Bap2p, indicating a high 
specificity of this permease. 
For uptake of L-leucine, three systems have previously 
been described; GAP1, the general amino acid permease, 
and two more specific transport systems, one with high 
affinity and low capacity (S 1) and another with low affin- 
ity and high capacity ($2) [20,21]. Bap2p might well 
correspond to one of the two kinetically described leucine 
transport systems. This study shows that Bap2p is involved 
in leucine transport, and suggests that at least one more 
uptake system in addition to Bap2p and Gaplp exists. In 
the present study, deletion of BAP2 reduces leucine up- 
take to about 50%. It is not known to what extent the 
remaining uptake goes via another permease specific for 
the branched-chain amino acids. It is possible that perme- 
ases with preference for other amino acids can transport 
leucine, isoleucine and valine to some extent, and that the 
uptake by these permeases increases when GAP1 and 
BAP2 are deleted. In analogy with this idea, we see 
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somewhat increased uptake of a few other amino acids in 
the deleted strain (cf. Fig. 3), suggesting slight activation 
of other permeases. 
BAP2 and TAT1 are located on chromosome II only 888 
by apart. A similar close position of two permease genes is 
seen for APL1, a putative amino acid permease [37], and 
the lysine permease, LYP1. These genes are separated by 
881 bp. However, whereas BAP2 and TAT1 are tran- 
scribed in the same direction, APL1 and LYP1 are tran- 
scribed in opposite directions. It is tempting to suggest a 
coordinated regulation of transcription of closely linked 
permease genes, but so far no experimental data can 
support his idea. In a comparison with other permease 
genes we found about 84% homology at the amino acid 
level between Bap2p and the putative permease Paplp 
[36], which differs from Bap2p primarily at the termini. 
When compared to Bap2p, Paplp is missing 28 amino 
acids at the C-terminus and 12 amino acids at the N- 
terminus. We hypothesize that the increased activity caused 
by a 29 amino acid C-terminal truncation of Bap2p reflects 
a regulatory role of this segment. In the general amino acid 
permease, Gaplp, phosphorylation a d dephosphorylation, 
probably near the C-terminus, has a decisive effect on 
activity [9,10]. Also, yeast and plant proton translocating 
ATPases have regulating, inhibitory domains near their 
C-terminus [38]. However, it is conceivable that the C- 
terminal truncation of the Bap2p permease stimulates up- 
take by alternative mechanisms, e.g., affecting targeting or 
turnover of the permease. 
The BAP2 promoter egion has putative binding sites 
for the transcription activators Leu3p and Gcn4p. Potential 
Gcn4p recognition sequences are also found in promoters 
of the amino acid permease genes HIP1 [6] and TAT2 [7]. 
The importance of the putative Gcn4p binding sites in 
these two promoters i different; increased levels of Gcn4p 
did not influence TAT2 expression [7], while it stimulated 
HIP1 expression [39]. We do not yet know roles for the 
Gcn4p binding site and the Leu3p binding site in the 
BAP2 promoter. 
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